Explore our core medical device portfolio. Designed with 1.1× USP tensile margin strength, ethylene oxide validated sterility, and full EU MDR technical dossiers for procurement across Finnish Wellbeing Services Counties (Hyvinvointialueet).
Monofilament absorbable barbed suture engineered with bi-directional and uni-directional cutting patterns for knotless tissue approximation.
Smooth, synthetic absorbable suture delivering extended wound support for fascia closure, orthopaedics, and paediatric cardiovascular surgery.
Coated Poly(glycolide-co-l-lactide) suture providing smooth passage through tissue and tight knot security for general closure.
High-tensile strength synthetic absorbable braided suture treated with polycaprolactone coating for precise handling.
Pliable monofilament synthetic absorbable suture tailored for skin closure, cosmetic procedures, and urological surgery.
Knitted non-absorbable polypropylene mesh engineered with optimized porosity for open and laparoscopic hernia repair (TAPP/TEP).
Absorbable warp-knitted plant-derived haemostatic matrix providing rapid intra-operative control of capillary and venous bleeding.
Opaque, non-absorbable blend of purified beeswax and isopropyl palmitate for mechanical haemostasis in osseous bleeding.
The Finnish medical device procurement ecosystem is undergoing a structural transformation driven by the centralization of public healthcare services into 21 Wellbeing Services Counties (Hyvinvointialueet) alongside the Helsinki University Hospital (HUS) system. Public tender procurement boards in Finland operate under stringent technical evaluation criteria regulated by the Finnish Act on Public Procurement and Concession Contracts (Hankintalaki 1397/2016) and supervised by Valvira (the National Supervisory Authority for Welfare and Health).
Within operating theaters across university medical centers—such as HUS Töölö Trauma Center, Tampere University Hospital (TAYS), and Oulu University Hospital (OYS)—the adoption of Polydioxanone (PDS) Barbed Sutures has accelerated dramatically. Surgical directors and procurement officers prioritize knotless tissue closure systems that minimize intra-operative time, decrease surgical site infection (SSI) risks, and deliver predictable tension distribution across high-stress muscular and fascial layers.
As a global pioneer in wound closure technologies, Unisur Lifecare Pvt. Ltd. (Universal Sutures) stands among an elite echelon of medical device manufacturers worldwide. Universal Sutures achieved distinction as the second Indian suture manufacturer to secure full EU Medical Device Regulation (EU MDR 2017/745) certification. Covering 13 comprehensive product families, our manufacturing infrastructure delivers total compliance, technical dossier transparency, and robust supply continuity to Finnish distributors, private hospital networks (such as Mehiläinen, Terveystalo, and Pihlajalinna), and public health tenders.
UNISYNTH® Polydioxanone Barbed Sutures are synthesized from 100% pure poly(p-dioxanone) polymer—a polyester-ether macromolecule characterized by repeating [-O-CH2-CH2-O-CH2-CO-]n ester link chains. The molecular architecture of polydioxanone grants exceptional structural stability, low tissue drag, and prolonged hydrolytic resistance in vivo.
The core advantage of our barbed PDS device lies in the precision machining of helical, microscopic retainers along the monofilament shaft. Utilizing micro-machining cold-cut technology, the barbs are cut at optimized angle and pitch configurations without weakening the tensile core of the suture strand:
| Polymer Metric / Specification | UNISYNTH® Barbed PDS | Conventional Monofilament PDS | Polyglactin 910 (Braided) | Monofilament Polypropylene |
|---|---|---|---|---|
| Chemical Composition | Poly(p-dioxanone) | Poly(p-dioxanone) | Poly(glycolide-co-l-lactide) | Isotactic Polypropylene |
| Absorption Profile | Absorbable (180–220 Days) | Absorbable (180–220 Days) | Absorbable (56–70 Days) | Non-Absorbable (Permanent) |
| Tensile Retention (In Vivo) | 75% at 2 wks / 50% at 4 wks | 75% at 2 wks / 50% at 4 wks | 75% at 2 wks / 50% at 3 wks | 100% Indefinite Retention |
| Knotting Mechanism | Knotless (Self-Anchoring Barbs) | Manual Surgical Knots Required | Manual Surgical Knots Required | Manual Surgical Knots Required |
| Tissue Reaction Grade | Very Low (Monofilament Ester) | Very Low (Monofilament Ester) | Low (Coated Braided Structure) | Extremely Inert |
| EU MDR Device Class | Class III (EU MDR 2017/745) | Class III (EU MDR 2017/745) | Class III (EU MDR 2017/745) | Class IIb / Class III (Mesh) |
Hydrolytic degradation of UNISYNTH® PDS occurs via passive cleavage of ester bonds by cellular moisture. The breakdown product, monomeric ether-ester acid, is fully metabolized by the body into water ($H_2O$) and carbon dioxide ($CO_2$), leaving zero persistent foreign debris. This extended absorption kinetics window (up to 7 months) renders Polydioxanone Barbed Sutures the gold standard for tissues under constant physical strain, such as Scandinavian patients undergoing aggressive rehabilitation post-total joint replacement.
Working in collaboration with chief medical officers and surgical supply partners in Finland, Universal Sutures has optimized product offerings for the specific operative techniques practiced across Nordic hospitals:
In total knee arthroplasty (TKA) and total hip arthroplasty (THA) performed at Specialized Joint Replacement Hospital Coxa in Tampere, UNISYNTH® Barbed PDS USP 2 and 1-0 are employed for deep capsular and fascial closure. The knotless barb distribution prevents suture slippage and joint fluid leakage under early postoperative weight-bearing.
During laparoscopic myomectomy and sacrocolpopexy at HUS Women's Hospital in Helsinki, space constraints hinder knot tying. UNISYNTH® Bi-Directional PDS Sutures allow seamless double-layer uterine reconstruction, cutting suture management time and lowering blood loss during endosurgery.
For laparoscopic Roux-en-Y gastric bypass pouch closure and mesenteric defect closure in Turku University Hospital (TYKS), monofilament barbed PDS provides watertight mucosal closure with minimal tissue trauma and zero risk of knot-induced ischemia or stenosis.
Universal Sutures (Unisur Lifecare Pvt. Ltd., an LVS Group Company) operates a state-of-the-art cleanroom manufacturing facility in Bengaluru, India. Designed around ISO 13485 quality systems and validated Ethylene Oxide (EO) terminal sterilization cycles, our infrastructure ensures total batch-to-batch repeatability and sterile barrier integrity.
Our operational superiority is grounded in five key enterprise pillars:
Every lot of UNISYNTH® PDS and barbed sutures is engineered to exceed USP and European Pharmacopoeia (EP) minimum tensile strength and needle-attachment pull-off standards by at least 10%, giving surgeons confidence during continuous high-tension suturing.
Over 70% of our production team consists of specialized women technicians trained in high-precision micro-needling, foil-sealing, and automated barb cutting under Class 7 cleanroom conditions.
We provide Finnish tender partners and medical distributors with complete technical documentation, Clinical Evaluation Reports (CER), and Post-Market Surveillance (PMS) data required for seamless compliance audits.
Direct answers regarding regulatory compliance, shipping logistics, private label OEM capabilities, and clinical performance in cold-climate healthcare supply chains.
Yes. Universal Sutures (Unisur Lifecare) holds full EU MDR (Regulation 2017/745) CE certification issued by Notified Body services. Our technical files and quality systems comply directly with Valvira regulations and the Finnish Medical Devices Act (719/2021), enabling public hospital procurement boards across all 21 Finnish Wellbeing Services Counties (Hyvinvointialueet) to register and deploy our devices immediately.
UNISYNTH® Barbed PDS sutures are sealed in double aluminum foil blister packs backfilled with inert dry nitrogen gas. This moisture-impermeable barrier protects the hydrolytically sensitive polydioxanone polymer against ambient humidity and temperature fluctuations during freight transport to northern hubs such as Rovaniemi or Oulu, guaranteeing a full 3-year shelf-life stability.
We supply high-grade 300-series and 400-series siliconized stainless steel needles featuring square-body ribbed profiles for superior needle-holder grip. Needle geometries include taper point, reverse cutting, precision point cosmetics, and heavy-duty orthopaedic taper cut needles tailored for dense fascia and capsular tissue.
Absolutely. Our OEM division provides turnkey private-label solutions for Finnish distributors and brand owners. We handle custom outer box designs, multi-language labeling (Finnish suomi and Swedish svenska), specific IFU translations, USP size assortments, and regulatory dossier transfer.
Standard export orders are processed and dispatched within 2 to 4 weeks from our Bengaluru facility. We coordinate with major international logistics partners (DHL, FedEx, air/sea freight forwarders) to ensure customs clearance and door-to-door delivery into Finnish logistics centers in under 7 business days.
By operating integrated vertical manufacturing—from raw filament extrusion to needle attachment and packaging under one ISO 13485 roof—Universal Sutures eliminates intermediary margins. We offer Finnish health authorities cost savings of 25% to 40% compared to legacy Western brands while maintaining superior 1.1× USP strength and EU MDR compliance.
Whether you are expanding your hospital supply catalog in Finland, bidding for regional public tenders (Hyvinvointialueet), or seeking an established OEM partner for knotless Polydioxanone Barbed Sutures, Universal Sutures delivers the quality, compliance, and volume capacity you require.
